UNSPSC 42143301: Chemotherapy administration sets or kits

In this classification, this commodity indicates a product that is a prepackaged collection (either custom or standard) of the equipment and supplies used to perform chemotherapy administration procedures in a medical setting. US FDA regulates Chemotherapy administration sets or kits under 21 CFR 880.5540 and under FDA product code FPA. Most nations, for tariff and trade purposes, schedule these products under HS 901890.

UNSPSC 42143301 Chemotherapy administration sets or kits is a Commodity code that, based on recent state and local procurement activity, encompasses clinical oncology imaging and data management platforms rather than physical chemotherapy administration kits. The University of Texas Health Science Center at San Antonio's recent solicitation (74526P43, posted June 29, 2026, due August 7, 2026) requests a comprehensive oncology clinical imaging and tumor measurement platform to standardize clinical research data, trial management, and radiology workflows across multiple imaging modalities. The platform must support DICOM-format radiology imaging, digital pathology, and emerging imaging modalities while maintaining HIPAA and FDA 21 CFR Part 11 compliance, with requirements for secure data acquisition and storage, interoperability across imaging systems, centralized data management, rapid study onboarding, and integration with Electronic Data Capture systems. The issuing body is a health science center within a public university system; the scope indicates a shift in how this code is being applied in practice, away from consumable administration kits toward enterprise imaging software supporting oncology clinical research and trial operations.

The single representative recent opportunity is geographically concentrated in Texas. The source provides no evidence of broader state or regional activity under this code, no additional issuing bodies using it, and no clear repeat-buyer pattern. The UTHSA opportunity represents an RFP issued directly by the health science center rather than a cooperative purchasing vehicle. The mismatch between the code's nominal scope—chemotherapy administration sets or kits—and the actual procurement (oncology imaging software) signals either a tagging misalignment in the source system or a significant drift in how state and local procurement offices classify oncology-related technology contracts. No contract value, term, or evaluation criteria are specified in the available source material.